Tina Tan’s Post

What's been buzzing the loudest for me so far at HLTH Europe? AI, AI, and more AI, of course. Tongues have been tripping over those two letters in every conversation I've had today or listened to including these nuggets: Michael Chen of Nuclera: "Generative AI is wonderful because it brings more hypothesis-making power for the drug discovery researcher. But ultimately, we all know that AI isn't enough. You need to have the power at the wet lab benchtop in order to validate experiments and bring hits and needs into the local trials, and the quality of these hits and leads that ultimately will help the success rates in phase one through three clinical trials, which often don't rear their ugly heads until it's too late." Geraldine O'Keeffe of EQT Group: "There's a huge amount of investment opportunity in terms of AI-, SaaS-based models, in big data and machine learning in diagnostics, precision medicine...delivering the care you need better, faster, cheaper." Karen DeSalvo of Google: "The availability of AI, the ubiquity of it, and just how quickly that is moving [has been significant in the evolution of AI in healthcare]. What I'm hoping now is the next generation of this technology allows us to democratise access to health for people all over the world, and that we can start to do that much more quickly and much more equitably." Chiara Bucciarelli-Ducci, MD, PhD and Marlies Schijven on clinicians' take on AI: "To scale up adoption of AI in healthcare, industry needs to demonstrate to clinicians and healthcare providers the cost effectiveness and cost efficiencies that the technology can bring at every level." "More often than not, we find that AI does work and helps to bring efficiencies, but it also carries risk. So it needs to be properly explained." Agree, disagree, or follow-up comments on these soundbites? #genAI #AIeverywhere #medicalAI #healthtech #digitalhealth #AIfordrugdiscovery #techbio #healthAI #clinicalAI

  • No alternative text description for this image
Eliane Boucher, PhD

Digital Health | Evidence Generation | Research Strategy | People Leader | Science Communicator | Behavioral Science | Recovered Academic

1mo

I just hope we're not just jumping on a bandwagon - everyone's talking about AI and there's a lot of buzz, but in healthcare we have a responsibility of considering the implications of biases that often exist in AI algorithms, the risks in generative AI, and people's preferences for how AI is actually used (e.g., there was some data suggesting people were uncomfortable with the idea of an "empathic" AI chatbot that tried to develop a relationship with them). I think we are in a strong position in digital health to ask these hard questions, explore impacts and potential solutions, and figure this all out - but we have to be willing to fight the push to jump on the bandwagon and to pause and ask the hard questions.

To view or add a comment, sign in

Explore topics